Related Experiment Video
Updated: Apr 18, 2026

06:43
Desensitization and Recovery of Crayfish Photoreceptors Upon Delivery of a Light Stimulus
Published on: November 9, 2019
7.1K
Time-varying pulse trains limit retinal desensitization caused by continuous electrical stimulation
Summary
This study introduces a new way to stimulate the retina to prevent vision loss from continuous electrical pulses in epiretinal prostheses for Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD). A novel stimulation pattern limits retinal desensitization, improving device efficacy.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Ophthalmology
Background:
- Epiretinal prostheses aim to restore vision in patients with Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD).
- These conditions cause photoreceptor loss, but other retinal cells remain viable for electrical stimulation.
- Continuous electrical stimulation can lead to retinal desensitization, reducing prosthesis effectiveness.
Purpose of the Study:
- To develop an in vivo model for studying retinal desensitization caused by electrical stimulation.
- To investigate a novel stimulation pattern designed to mitigate retinal desensitization.
- To improve the long-term efficacy of epiretinal prostheses.
Main Methods:
- Establishment of an in vivo model of retinal desensitization.
- Application of continuous biphasic stimulus pulses.
- Implementation and testing of a novel stimulation pattern.
Main Results:
- The study successfully modeled retinal desensitization in vivo.
- The novel stimulation pattern was shown to limit desensitization compared to continuous stimulation.
- This suggests a potential improvement in visual percept brightness and reduced stimulus thresholds.
Conclusions:
- Continuous electrical stimulation causes retinal desensitization, impacting epiretinal prosthesis function.
- A novel stimulation pattern effectively limits this desensitization.
- This finding offers a promising strategy for enhancing visual restoration in patients with RP and AMD.

